Study: Creating a Diversity Score Could Improve Medical Research

September 29, 2022

(Axios) – Measuring racial and ethnic diversity within medical trials — and requiring a certain threshold to be met for researchers to publish in major journals — could be key to improving research into cancer and other diseases, a recent study found. The big picture: White non-Hispanics made up 75% of all participants in medical research trials in 2020, the last year for which data is available, an FDA report shows. That means treatments or cures developed through research that largely excludes Latinos and other demographics might not work for them or cause unforeseen side effects. (Read More)